RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,191,264 | +26095.4% | 182,825 | +25152.1% | 0.00% | – |
| Q2 2020 | $16,000 | +45.5% | 724 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -35.3% | 724 | -3.2% | 0.00% | – |
| Q4 2019 | $17,000 | +6.2% | 748 | 0.0% | 0.00% | – |
| Q3 2019 | $16,000 | -97.6% | 748 | -97.6% | 0.00% | -100.0% |
| Q2 2019 | $677,000 | -19.8% | 30,795 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $844,000 | +1.9% | 30,795 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $828,000 | -7.9% | 30,792 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $899,000 | -6.7% | 30,807 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $964,000 | +26.7% | 30,854 | -19.4% | 0.00% | 0.0% |
| Q1 2018 | $761,000 | +1363.5% | 38,264 | +2040.0% | 0.00% | – |
| Q4 2017 | $52,000 | – | 1,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |